cerebral arteriovenous malformation (cerebral AVM, intracranial AVM)

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

  • most commonly produce symptoms in the 2nd & 3rd decade of life

Pathology

Genetics

Clinical manifestations

Radiology

Management

More general terms

More specific terms

References

  1. UCLA Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
  2. 2.0 2.1 2.2 Mohr JP et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): A multicentre, non-blinded, randomised trial. Lancet 2013 Nov 20 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62302-8/fulltext
  3. 3.0 3.1 Salman RA-S et al. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014 Apr 23; 311:1661 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24756516
  4. 4.0 4.1 4.2 4.3 Nikolaev SI, Vetiska S, Bonilla X et al Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain. N Engl J Med 2018; 378:250-261. January 18, 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29298116 Free full text <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1709449
  5. NINDS Arteriovenous Malformation Information Page https://www.ninds.nih.gov/Disorders/All-Disorders/Arteriovenous-Malformation-Information-Page

Patient information

cerebral arteriovenous malformation patient information

Database